Inhalational delivery of induced pluripotent stem cell secretome improves postpneumonectomy lung structure and function

被引:6
|
作者
Dane, D. Merrill [1 ]
Cao, Khoa [1 ]
Zhang, Yu-An [1 ]
Kernstine, Kemp H. [2 ]
Gazdhar, Amiq [3 ,4 ]
Geiser, Thomas [3 ,4 ]
Hsia, Connie C. W. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Cardiothorac & Thorac Surg, Dallas, TX 75390 USA
[3] Univ Bern, Dept Pulm Med, Bern, Switzerland
[4] Univ Bern, Dept BioMed Res, Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
alveolar remodeling; compensatory lung growth; induced pluripotent stem cells; lung diffusing capacity; secretome; PRESSURE-VOLUME CHARACTERISTICS; LONG-TERM POSTPNEUMONECTOMY; VIVO MECHANICAL STIMULI; DIFFUSING-CAPACITY; CARDIOPULMONARY ADAPTATIONS; BRONCHOPULMONARY DYSPLASIA; GROWTH; INJURY; PNEUMONECTOMY; MEMBRANE;
D O I
10.1152/japplphysiol.00205.2020
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cell-free secretory products (secretome) of human induced pluripotent stem cells (iPSCs) have been shown to attenuate tissue injury and facilitate repair and recovery. To examine whether iPSC secretome facilitates mechanically induced compensatory responses following unilateral pneumonectomy (PNX), litter-matched young adult female hounds underwent right PNX (removing 55%-58% of lung units), followed by inhalational delivery of either the nebulized-conditioned media containing induced pluripotent stem cell secretome (iPSC CM) or control cell-free media (CFM); inhalation was repeated every 5 days for 10 treatments. Lung function was measured under anesthesia pre-PNX and 10 days after the last treatment (8 wk post-PNX); detailed quantitative analysis of lung ultrastructure was performed postmortem. Pre-PNX lung function was similar between groups. Compared with CFM control, treatment with iPSC CM attenuated the post-PNX decline in lung diffusing capacity for carbon monoxide and membrane diffusing capacity, accompanied by a 24% larger postmortem lobar volume and distal air spaces. Alveolar double-capillary profiles were 39% more prevalent consistent with enhanced intussusceptive angiogenesis. Frequency distribution of the harmonic mean thickness of alveolar blood-gas barrier shifted toward the lowest values, whereas alveolar septal tissue volume and arithmetic septal thickness were similar, indicating septal remodeling and reduced diffusive resistance of the blood-gas barrier. Thus, repetitive inhalational delivery of iPSC secretome enhanced post-PNX alveolar angiogenesis and septal remodeling that are associated with improved gas exchange compensation. Results highlight the plasticity of the remaining lung units following major loss of lung mass that are responsive to broad-based modulation provided by the iPSC secretome. NEW & NOTEWORTHY To examine whether the secreted products of human induced pluripotent stem cells (iPSCs) facilitate innate adaptive responses following loss of lung tissue, adult dogs underwent surgical removal of one lung, then received repeated administration of iPSC secretory products via inhalational delivery compared with control treatment. Inhalation of iPSC secretory products enhanced capillary formation and beneficial structural remodeling in the remaining lung, leading to improved lung function.
引用
收藏
页码:1051 / 1061
页数:11
相关论文
共 50 条
  • [41] Transactivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced Pluripotent Stem Cell
    Nordin, Fazlina
    Ahmad, Raja Norazireen Raja
    Farzaneh, Farzin
    VIRUS RESEARCH, 2017, 235 : 106 - 114
  • [42] Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
    Galat, Vasiliy
    Galat, Yekaterina
    Perepitchka, Mariana
    Jennings, Lawrence J.
    Iannaccone, Philip M.
    Hendrix, Mary J. C.
    STEM CELLS AND DEVELOPMENT, 2016, 25 (14) : 1060 - 1072
  • [43] Stem cell secretome attenuates acute rejection in rat lung allotransplant
    Pierog, Jaroslaw
    Fytianos, Kleanthis
    Tamo, Luca
    Simillion, Cedric
    Taddeo, Adriano
    Kocher, Gregor
    Gugger, Mathias
    Grodzki, Tomasz
    Heller, Manfred
    Blank, Fabian
    Geiser, Thomas
    Schmid, Ralph A.
    Gazdhar, Amiq
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 28 (05) : 812 - 818
  • [44] A Combinatorial Approach Comprehensively Improves The Maturation Of Human Induced Pluripotent Stem Cell Derived Atrial Cardiomyocytes
    Ly, Olivia T.
    Brown, Grace
    Chen, Hanna
    Hong, Liang
    Wang, Xinge
    Han, Yong Duk
    Pavel, Mahmud Arif
    Sridhar, Arvind
    Maienschein-Cline, Mark
    Youn, Seock Won
    Chalazan, Brandon
    CIRCULATION RESEARCH, 2021, 129
  • [45] PLURIPOTENT STEM CELL FUNCTION OF MOUSE MARROW LYMPHOCYTE
    CUDKOWICZ, G
    SHEARER, GM
    BENNETT, M
    SCIENCE, 1964, 144 (362) : 866 - &
  • [46] Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia
    Qanash, Husam
    Li, Yongqin
    Smith, Richard H.
    Linask, Kaari
    Young-Baird, Sara
    Hakami, Waleed
    Keyvanfar, Keyvan
    Choy, John S.
    Zou, Jizhong
    Larochelle, Andre
    CELLS, 2021, 10 (04)
  • [47] Induced pluripotent stem cell technology and stem cell therapy for diabetes (Review)
    Drummond, Robert J.
    Kunath, Tilo
    Mee, P. Joseph
    Ross, James A.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (01) : 3 - 7
  • [48] Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation
    Jarosław Lewandowski
    Maciej Kurpisz
    Archivum Immunologiae et Therapiae Experimentalis, 2016, 64 : 349 - 370
  • [49] Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation
    Lewandowski, Jaroslaw
    Kurpisz, Maciej
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (05) : 349 - 370
  • [50] Development of process analytical technology to monitor the cell secretome during differentiation of pluripotent stem cells
    Ricardo, C. Pinto
    Evie, I.
    Henry, M.
    Sanchez-Nieto, J. M.
    Jayawardena, M.
    Soula, A.
    Daldoul, K.
    Arya, M.
    O'Grady, C.
    Dewhirst, O.
    Smart, M.
    Munye, M.
    Hasan, J.
    CYTOTHERAPY, 2020, 22 (05) : S45 - S46